Zobrazeno 1 - 10
of 93
pro vyhledávání: '"B. J. Krause"'
Autor:
C. Roolf, A. Richter, C. Konkolefski, G. Knuebel, A. Sekora, S. Krohn, J. Stenzel, B. J. Krause, B. Vollmar, H. Murua Escobar, C. Junghanss
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-13 (2018)
Abstract Background Promotor hypermethylation of CpG islands is common in B cell precursor acute lymphoblastic leukemia (BCP-ALL) with mixed lineage leukemia (MLL) gene rearrangements. Hypomethylating agents (HMA) such as azacitidine (AZA) and decita
Externí odkaz:
https://doaj.org/article/45601950b7b64166967ef05f6a062b47
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-11 (2018)
Abstract Background Prostate-specific membrane antigen (PSMA)-targeted therapy with 177Lu-PSMA-617 is a therapeutic option for patients with metastatic castration-resistant prostate cancer (mCRPC). To optimize the therapy procedure, it is necessary t
Externí odkaz:
https://doaj.org/article/13f0405c543449f491200c165a680d5f
Publikováno v:
Der Radiologe. 60(12)
The goal of this article is to shed light on innovations in perfusion imaging and the fields of application that have opened up in hybrid imaging of the heart.As before, the most commonly used modalities in hybrid imaging are single photon emission c
Publikováno v:
Der Urologe. Ausg. A. 59(5)
In recent years nuclear medicine theranostics using radiolabeled prostate-specific membrane antigen (PSMA) ligands have gained increasing importance in the management of prostate cancer.The aim of this work is to highlight the value of theranostic co
Publikováno v:
Nuklearmedizin. 54:69-74
ZusammenfassungÜbersichtsarbeiten stellen einen wichtigen Teil medizinischer Literatur dar und ermöglichen dem Leser innerhalb kurzer Zeit einen umfassenden Überblick über ein bestimmtes Thema zu bekommen. In der Radiologie und der Nuklearmedizin
Publikováno v:
EJNMMI Research
Background Prostate-specific membrane antigen (PSMA)-targeted therapy with 177Lu-PSMA-617 is a therapeutic option for patients with metastatic castration-resistant prostate cancer (mCRPC). To optimize the therapy procedure, it is necessary to determi
Publikováno v:
Nervenheilkunde 32(10), 725-732 (2013). doi:10.1055/s-0038-1633362
ZusammenfassungDurch die Entwicklung molekularer Marker der zerebralen Amyloidablagerung in vivo hat die Positronenemissionstomografie (PET) eine zentrale Rolle für die Definition präklinischer und prädemenzieller Stadien der Alzheimer Krankheit e
Autor:
S. Ziegler, U. Treiber, David H. Sachs, M. Schwaiger, Tibor Schuster, B. J. Krause, S. Schwarzenböck, Hans Wester, M. Souvatzoglou, R. Nawroth, Gregor Weirich, R. Senekowitsch-Schmidtke
Publikováno v:
Nuklearmedizin. 52:141-147
SummaryThe aim of this study was to determine whether [11C]choline can be used for docetaxel therapy response assessment in a LNCaPprostate cancer xenograft mouse model using [11C]choline small-animal PET/CT. Animals, methods: The androgen-dependent
Publikováno v:
Theranostics, Vol 2, Iss 1, Pp 318-330 (2012)
PET and PET/CT using [11C]- and [18F]-labelled choline derivates is increasingly being used for imaging of primary and recurrent prostate cancer. While PET and PET/CT with [11C]- and [18F]-labelled choline derivates in patients suffering from biochem
Publikováno v:
Nuklearmedizin. 49:195-201
SummaryIn nuclear medicine, bone scanning is based on the principle of scintigraphy using boneseeking radiopharmaceuticals which accumulate in sites of increased bone formation. From a historical point of view, 18F-fluoride was one of the first osteo